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microRNA is a subset of endogenous non-coding RNA. It binds to partially complementary
sequences in mRNAs and inhibits mRNA translation by either blocking translational
machinery or degrading mRNAs. It is involved in various cellular processes including
cell cycle, development, metabolism, and synaptic plasticity. Dysregulation of miRNA
expression and function is reported in various diseases including cancer, metabolic
disorders as well as neurological disorders. In nervous system, miRNA related pathways
play a very important role in development and function of neuronal cells. Moreover,
numerous evidences suggest that dysregulated miRNA related pathways contribute to
pathology of neurological disorders such as Alzheimer’s disease, amyotrophic lateral
sclerosis (ALS) and spinal muscular atrophy (SMA). Here, we review current knowledge
about the role of miRNAs in motor neuron disorders, especially about two common
diseases: SMA and ALS.
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INTRODUCTION
microRNAs (miRNAs) are endogenous non-coding single-
stranded RNA molecules that play important roles in eukaryotic
gene expression through posttranscriptional regulation (Bartel,
2009). It mainly binds to the 3′-untranslated region (3′-UTR)
of messenger RNAs (mRNAs) from target protein-coding genes
and leads to gene silencing by mRNA cleavage, translational
repression and deadenylation (Huntzinger and Izaurralde, 2011).
Functional studies indicate that miRNA plays a signiﬁcant role
in a broad range of cellular and developmental processes such
as stem cell maintenance (Houbaviy et al., 2003), differentiation
(Chen et al., 2004; Naguibneva et al., 2006), cell cycle (Hatﬁeld
et al., 2005), development (Hornstein et al., 2005), learning and
memory formation (Gao et al., 2010), energy metabolism (Gao
et al., 2009), and immune responses (Xiao et al., 2007). miRNAs
can only function as part of ribonucleoprotein (RNP) complex
called RNA induced silencing complex (RISC), which contains
various proteins such as argonautes, fragile X mental retardation
protein (FMRP), Dicer and monkey leukemia virus 10 (MOV10;
Jin et al., 2004; Landthaler et al., 2008). Like miRNAs, RISC plays
a crucial role in many cellular processes during development and
cellular differentiation. For example, deletion of core protein of
RISC, Ago2 leads to embryonic lethality in mouse (Morita et al.,
2007). Similarly, ablation of Dicer or DiGeorge syndrome criti-
cal region gene 8 (DGCR8) also causes developmental arrest in
murine embryonic stem cells (Bernstein et al., 2003; Wang et al.,
2007). Although it is widely accepted that miRNAs are important
for nervous system development and function, a little is known
about the role of individual miRNAs in neuron at the moment.
BIOGENESIS AND DECAY OF miRNAs
The majority of characterized miRNAs are transcribed by RNA
polymerase II from their own independent genes or introns of
protein-coding genes (Krol et al., 2010). The primary transcript
(pri-miRNAs) of miRNA is speciﬁcally recognized by micropro-
cessor complex. The microprocessor complex is composed by
nuclear ribonuclease III, Drosha, and its binding partner, DGCR8.
In this complex, a double stranded RNA-binding protein, DGCR8
recognizes the stem-loop structure in pri-miRNA and Drosha
cleaves the pri-miRNA into a∼70-nucleotide precursor form (pre-
miRNA). Afterward, pre-miRNA is translocated to the cytoplasm
by exportin 5 through the nuclear pore complex in a Ran guano-
sine triphosphate (RanGTP)-dependent process. In the cytoplasm,
second RNaseIII containing protein complex cleaves pre-miRNA
to ∼20 bp miRNA/miRNA* duplex. This complex is composed of
Dicer (RNaseIII), transactivation response RNA binding protein
(TRBP), and protein activator of the interferon-induced protein
kinase (PACT). One strand of the miRNA duplex is incorporated
into the RISC as amaturemiRNA (guide strand/miRNA),whereas
the other strand (passenger strand/miRNA∗) is degraded (Kim
et al., 2009).
miRNA can only function in the RISC. The functional core pro-
teins of RISC aremainly composed of Argonaute families (Ago1-4)
and glycin-tryptophanprotein of 182 kDa (GW182). InRISC,only
Agonaute proteins show endonuclease enzymatic activity, which
is responsible for mRNA silencing (Huntzinger and Izaurralde,
2011). GW182 proteins are also essential for the RISC function
(Eulalio et al., 2008). It inhibits binding of poly-A binding protein
(PABPC) to poly-A tail and induces deadenylation, decapping, and
decay of mRNAs (Zekri et al., 2009). Additional proteins associ-
ated with RISC have been identiﬁed such as FMRP, MOV10, and
Hu-Antigen R (HuR; Landthaler et al., 2008).
Expression of miRNAs seems to be tightly regulated by sophis-
ticated mechanisms from the biogenesis to decay. Although it is
not yet fully understood, the stability of mature miRNA is con-
trolled by endogenous factors such as miRNA degrading enzymes
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and occupancy by target mRNAs. In animal cells, miRNA decay
is carried out by the 5′-to-3′ exoribonuclease 1 and 2 (XRN1 and
XRN2; Bail et al., 2010). Interestingly, it seems that binding to
their target mRNAs can increase or decrease stability of miRNAs
(Chatterjee et al., 2011; Iio et al., 2013). Additionally, environmen-
tal factors such as growth factors, cell cycle, and neuronal activity
can inﬂuence on stability of miRNAs (Ruegger and Grosshans,
2012).
miRNA IN MOTOR NEURONS
Numerous studies have shown that miRNAs play an impor-
tant role for nervous system development (Conaco et al., 2006;
Akerblom et al., 2012; Zhu et al., 2013). Disturbing miRNA bio-
genesis pathway by deleting Dicer1 from spinal motor neurons
in mouse caused spinal muscular atrophy (SMA) like pheno-
type (Haramati et al., 2010). More speciﬁcally, modifying miR-9
expression in developingmotor neurons alters motor neuron sub-
type speciﬁcation as well as columnar development of spinal
cords in chick embryos (Otaegi et al., 2011a). In this model,
miR-9 regulates expression of transcription factor, forkhead box
P1 (FoxP1), which plays a crucial role for development and
neuronal subtype differentiation in spinal cord (Otaegi et al.,
2011b). Another interesting miRNA in motor neuron is miR-
17-3p. This miRNA directly regulates mRNA translation of
oligodendrocyte transcription factor 2 (Olig2), which is an impor-
tant transcription factor for spinal motor neuron differentiation.
The expression of miR-17-3p is repressed by sonic hedgehog
(Shh), which results in elevated expression of Olig2. Thus, high
amount of Shh will direct neuronal progenitors to differenti-
ate toward motor neurons and decrease interneuron population.
Additionally, deletion of miR-17∼92 cluster frommouse embryos
suggests that this cluster regulates differentiation of interneu-
rons as well as motor neurons in early spinal cord development
(Chen et al., 2011). Table 1 summarizes motor neuron related
miRNAs discussed in this review.
miRNAs are also important for axonal regeneration process in
spinal motor neurons. Ablation of Dicer in sciatic nerve of mouse
suggested that functional miRNAs are pivotal for nerve regenera-
tion and axonal re-growth (Wu et al., 2012). In zebraﬁsh, elevated
expression of miR-133b after spinal cord injury represses mRNA
translation of RhoA. This process promotes functional recovery
of motor neuron axons after traumatic injury (Yu et al., 2011).
Taken together, we can conclude that miRNAs play a signiﬁcant
role in various processes in motor neurons such as neuronal sub-
type speciﬁcation, functional maintenance, and regeneration after
injury.
miRNA AT THE NEUROMUSCULAR JUNCTION
miRNAs are differentially distributed in neuronal compartments
such as soma and neurites (Kye et al., 2007). Numerous miRNAs
are presented in axonal compartment and growth cones in corti-
cal and sympathetic neurons (Natera-Naranjo et al., 2010; Sasaki
et al., 2013). These data suggests that miRNAs can regulate mRNA
translation at the axonal compartments. It seems thatmiRNAsplay
a signiﬁcant role in motor neuron axons, especially at the neuro-
muscular junction (NMJ). Interestingly, in contrast to vertebrates,
Drosophila mutant, who lacks one of the most abundant neuronal
miRNA, miR-124 did not show any strong defect in neuronal
production, differentiation, and NMJ morphology. However, the
miR-124 Drosophila mutant showed shorter life span, impaired
locomotion as well as increased presynaptic neurotransmitter
release at the NMJ (Sun et al., 2012). Additionally, miR-8 is also
reported as an important miRNA for pre-synaptic bouton forma-
tion at the Drosophila NMJ. Repeated neuronal activity represses
the expression of miR-8, and it results in elevated neuronal mRNA
translation and synaptic growth (Nesler et al., 2013). Drosophila
mutants lacking miR-125 or let-7 expression also showed defects
in NMJ phenotypes such as delayed maturation of NMJ, smaller
size of NMJ, and abnormality in locomotion. Interestingly, these
phenotypes are shown only during metamorphosis (Caygill and
Johnston, 2008). This implies that miRNAs play a speciﬁc role
for temporal and spatial regulation of gene expression during
development. Another interesting miRNA is miR-310. It regu-
lates synaptic homeostasis at the NMJ by regulating translation of
kinesin super family member, Khc-73. miR-310 directly represses
the translation of Khc-73 to control neurotransmitter release
in motor neurons during larval stages (Tsurudome et al., 2010).
Finally, function of miRNA at mammalian NMJ is described in a
mouse model for neuromuscular disease, slow-channel congeni-
tal myasthenic syndrome (SCS). Axonal expression of miR-124 is
elevated in this model compared to the wild type animals. miR-
124 regulates mRNA translation of Rab3a in axon in response
to ampliﬁed Ca2+/calpain/cdk5/nitric oxide pathway in muscle
cells. In consequence, the elevated expression of miR-124 and
reduced expression of Rab3a proteins in nerve terminals decrease
neurotransmitter release to the NMJ (Zhu et al., 2013). Taken
together, we can conclude that miRNAs are important players
for NMJ formation and function as well as maintaining synaptic
homeostasis.
Recently, protein and nucleic acids containing vesicles (exo-
somes) have been suggested as a new molecular mechanism for
communication between cells in nervous system (Sharma et al.,
2013). They can transfer genetic molecules from donor cells to
recipient cells, by which they can change physiology of recipient
cells (Valadi et al., 2007). For example, cancer cells release more
exosomes thanhealthy ones. In consequence, it changes physiology
of surrounding cells to have more favorable conditions for their
metastasis (Grange et al., 2011; Soldevilla et al., 2013). Moreover,
various miRNAs are detected in exosomes released from neurons
and muscle cells (Forterre et al., 2013; Fruhbeis et al., 2013). These
ﬁndings strongly suggest that miRNA can function as a signaling
molecule for intracellular communication at the NMJ.
TWO COMMON MOTOR NEURON DISEASES; SMA AND ALS
PROXIMAL SPINAL MUSCULAR ATROPHY
Spinal muscular atrophy is a genetically and clinically hetero-
geneous group of neuromuscular disorders characterized by
progressive degeneration of lower alpha motor neurons in the
anterior horn of spinal cord (Crawford and Pardo, 1996). Affected
individuals exhibit proximal manifestation of muscle weakness
and atrophy.With an incidence of 1:6000∼ 1:10000 newborns and
a carrier frequency of 1:35, proximal SMA is the leading heredi-
tary cause of infantmortality (Wirth et al., 2006). Due to the highly
variable disease severity, four clinical types of SMA are classiﬁed
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Table 1 |The list of motor neuron related miRNAs discussed in this review.
miRNA Findings Target genes Related disease/model
organism
Reference
miR-8 Presynaptic bouton formation/synaptic growth Lar and Wg Fruit ﬂy Nesler et al. (2013)
miR-9 Motor neuron subtype speciﬁcation/spinal cord
development
FoxP1 Chick Otaegi et al. (2011a,b)
Dysregulated expression in motor neurons
differentiated from embryonic stem cells
SMA/mouse Haramati et al. (2010)
Expression is elevated in induced stem cell
derived neurons from ALS patient
ALS/cell line (Human) Zhang et al. (2013)
Axon growth MAP1B Mouse Dajas-Bailador et al. (2012)
miR-17-3p Spinal motor neuron differentiation Olig2 Mouse Chen et al. (2011)
miR17∼92 cluster Differentiation of interneuron and motor
neurons
Mouse Chen et al. (2011)
miR-21 Axonal regeneration Sprouty2 Mouse Strickland et al. (2011)
Spinal cord injury PTEN and FasL Rat Hu et al. (2013)
miR-23a,
miR-29b, and
miR-455
Expression is increased in skeletal muscle
from ALS patients and it may cause
dysregulation in mitochondrial gene expression
PGC1-α (miR-23a) ALS/mouse Russell et al. (2012)
miR-106 Regeneration of NMJ HDAC4 ALS/mouse Williams et al. (2009)
miR-124 Neurotransmitter release Fruit ﬂy Sun et al. (2012)
Neurotransmitter release at the NMJ Rab3a Slow-channel congenital
myasthenic
syndrome/mouse
Zhu et al. (2013)
miR-125 and let-7 NMJ phenotype, delayed maturation, smaller
size, abnormal locomotion, reduced lifespan
Abrupt Fruit ﬂy Caygill and Johnston (2008)
miR-132 Neuronal morphology and cognition AChE and p250GAP ALS/mouse Edbauer et al. (2010), Shaltiel
et al. (2013)
Splicing of Tau PTBP2 Tauopathies/mouse Smith et al. (2011), Hebert et al.
(2012)
miR-132,
miR-143, and
miR-558
Expression is dysregulated in TDP-43 deﬁcient
cells. Neurites outgrowth (miR-132)
ALS and FTLD
(frontotemporal lobar
degeneration)/cell line
(mouse)
Kawahara and Mieda-Sato (2012)
miR-133b Spinal cord regeneration RhoA Zebraﬁsh Yu et al. (2011)
miR-134 Neuronal development and dendritogenesis Pumilio2 Mouse Fiore et al. (2009)
miR-138 Axonal regeneration SIRT1 Mouse Liu et al. (2013)
miR-310 Neurotransmitter release at the NMJ Khc-73 Fruit ﬂy Tsurudome et al. (2010)
miR-338-3p Expression is elevated in ALS patients ALS/human De Felice et al. (2012)
miR-431 Axonal regeneration and outgrowth Kremen1 Mouse Wu and Murashov (2013)
miR-451 Dysregulated in immune cells (with many
other miRNAs)
ALS/mouse Butovsky et al. (2012)
based on the age of onset and achieved motor abilities: Type I
SMA (Werdnig–Hoffmann), intermediate Type II SMA,mild Type
III SMA (Kugelberg–Welander), and Type IV SMA (adult SMA;
Pearn, 1980; Wirth et al., 2013).
Survival of motor neuron 1 (SMN1) is the major disease-
determining gene of SMA. SMA is caused by homozygous deletion
or mutation of SMN1 (Lefebvre et al., 1995). This gene is located
on the chromosomal region 5q11.2-13.3 in a segment of ∼500 kb,
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which includes the telomeric SMN1 and the similar but slightly
different centromeric SMN2. SMN2, which is >99% identical to
SMN1, has only a reduced capacity for correct splicing due to a
single silentmutation in exon7. SMN2 produces about 10%of full-
length SMN2 RNA that encodes a protein identical to the one from
SMN1. SMN2, which can vary from one to six copies per genome,
is the main modiﬁer of SMA and inﬂuences on SMA severity.
The severity of SMA can be affected by various genetic factors
(Wirth et al., 2013). The human SMN protein is a 38 kDa pro-
tein,which formsmulti-protein complexwith its binding partners,
seven Gemins (Gemin 2–8). Self-oligomerization of SMN creates
the backbone of the complex (Battle et al., 2006). SMN is ubiqui-
tously expressed and can be found in the nucleus as well as in the
axons and dendrites of neurons (Cougot et al., 2008; Akten et al.,
2011). In the nucleus, SMN is localized in subcellular structures
called gems, where it interacts with a number of proteins that are
essential for RNA processing and splicing (Pellizzoni et al., 1998).
In the axons, SMN interacts with RNA-binding proteins, such as
HuD, and plays a role in RNP trafﬁcking for local mRNA trans-
lation (Akten et al., 2011; Fallini et al., 2011). SMN also binds to
FMRP (Piazzon et al., 2008), KH-type splicing regulatory protein
(KSRP; Tadesse et al., 2008) and fused in sarcoma (FUS; Yamazaki
et al., 2012), which are important for miRNA biogenesis and
function.
AMYOTROPHIC LATERAL SCLEROSIS
Amyotrophic lateral sclerosis (ALS) is a progressive neurode-
generative disorder, which leads to death within 2–3 years of
onset. It is one of the most common motor neuron diseases
occurring 1.7 ∼ 2.3 out of 100,000 person per year in world-
wide (Beghi et al., 2006). The symptom of ALS usually starts
after age 50, but it can happen in younger age group. The dis-
ease manifests itself by onset of degeneration in speciﬁc subset
of motor neurons. It progressively spreads to neighboring motor
neurons and leads to atrophy of associated muscle tissues (Pratt
et al., 2012). The genetic and environmental causes of ALS is
still under investigation, but 90% of them are sporadic or from
unknown genetic factors. So far only about 10% of the cases can
be traced to genetic factors (Al-Chalabi et al., 2012). The most
well known genetic cause of ALS is mutations in or deletion
of Cu/Zn Super Oxide Dismutase 1 (SOD1; Rosen et al., 1993).
Only recently, with advanced genomic screening tools, several
other genes associated with ALS have been identiﬁed includ-
ing TAR DNA-binding protein (TDP-43), FUS, ALS 2 (ALS2),
neuroﬁlament heavy peptide (NEFH ; Al-Chalabi et al., 2012)
and C9ORF72 (DeJesus-Hernandez et al., 2011; Renton et al.,
2011). However, the cellular and pathological mechanisms caus-
ing ALS due to mutation or deletion of these genes are still under
investigation.
miRNA IN MOTOR NEURON DISEASES
The role of miRNA and their target genes are intensively stud-
ied in cancer ﬁeld. Studies in cancer cells suggest us that
miRNA are involved in many different pathways and their dys-
regulation can cause various types of cancers (Esteller, 2011;
Jansson and Lund, 2012). While the role of individual miRNAs
in neurological disorders is not yet fully understood, there are
growing evidences that miRNAs play a critical role in neurological
disorders, such as miR-206/miR-153 in Alzheimer’s disease (Lee
et al., 2012; Liang et al., 2012), miR-34b/miR-9/miR-9∗ in Hunt-
ington’s disease (Packer et al., 2008; Gaughwin et al., 2011),
miR-128a/miR-24/let-7b in mood disorder (Zhou et al., 2009),
miR-189 in Tourette’s syndrome (Abelson et al., 2005), miR-9
in SMA (Haramati et al., 2010), miR-106/miR-338-3p/miR-451 in
ALS (Williams et al., 2009; Butovsky et al., 2012; De Felice et al.,
2012), miR-21/miR-431/miR-138 for axonal regeneration for sen-
sory neurons (Strickland et al., 2011; Liu et al., 2013; Wu and
Murashov, 2013), and miR-133b/miR-21 for spinal cord injury
(Yu et al., 2011; Hu et al., 2013). However, pathological contribu-
tion of individual miRNAs to each of these diseases is still under
investigation. Especially, our knowledge about the role of miRNAs
in motor neuron diseases is very limited. This can be both due to
the complexity of the nervous system and the technical difﬁculties
of studying neurological disorders. In this section, wewill focus on
miRNA related dysregulation in twomotor neuron diseases; SMA,
and ALS.
miRNA IN SPINAL MUSCULAR ATROPHY PATHOLOGY
As it is mentioned above, SMN is a RNA binding protein,
which forms a complex with other Gemin proteins, Gemin2-8
(Battle et al., 2006). Among the Gemins, Gemin3 and Gemin4
also bind to Ago2, which served the core protein in RISC and
plays a role in miRNA biogenesis (Mourelatos et al., 2002). More-
over, numerous miRNAs bind to Gemin3 in human and murine
neuronal cell lines (Dostie et al., 2003). From these reports, we
can reason that the SMN complex is involved in miRNA bio-
genesis and/or function. In fact, expression of miRNAs such as
miR-9 and miR-9* were dysregulated in murine embryonic stem
cell derived motor neurons harboring a mutation causing SMA
(Haramati et al., 2010). However, cellular mechanisms underlying
in SMN mediated miRNA expression and/or function is not yet
identiﬁed.
Dicer is an RNase playing a role in miRNA biogenesis pathway.
The enzymeacts on the stem-loop shapeof precursormiRNA(pre-
miR) and creates a doubles stranded-miRNAs by cleaving the loop
structure off from the pre-miR (Bernstein et al., 2001). It seems
that a group of miRNAs get mature by Dicer, while other subset
of miRNAs are processed by Ago2 (Chelouﬁ et al., 2010). Thus,
deletion of either Dicer or Ago2 protein in cell may lead to severe
impairments in miRNA biogenesis and function. In fact, dele-
tion of Dicer in post-mitotic motor neuron causes motor neuron
degeneration, similar to the neuromuscular phenotype observed
in mouse model for SMA (Haramati et al., 2010).
miRNA IN AMYOTROPHIC LATERAL SCLEROSIS PATHOLOGY
Dysregulation inmiRNA expression andmiRNA-related pathways
are also reported in ALS. The expression of miR-206, a skeletal
muscle speciﬁc miRNA,was increased in muscle after denervation
of sciatic nerve and its deﬁciency synergistically worsened disease
progress in ALS mouse model harboring a disease causing muta-
tion in superoxide dismutase, SOD1. In this study, the elevated
expression of miR-206 after denervation promotes reinnervation
process at the NMJ via regulating histone deacetylase 4 (HDAC4)
and ﬁbroblast growth factor (FGF) pathway (Williams et al., 2009).
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This study is the ﬁrst report suggesting the role of miRNA for
nerve regeneration at the NMJ. Recently, additional report showed
that the expression of miR-23a, miR-29b, and miR-455 are ele-
vated in skeletal muscle tissues from ALS patients and this may
cause dysregulation in mitochondrial gene expression (Russell
et al., 2012). These ﬁndings hint us that dysregulated expres-
sion of miRNA in muscle cells signiﬁcantly contributes to ALS
pathology.
Another ALS associated gene, TAR DNA-binding protein-43
(TDP-43) is directly involved in miRNA pathway. TDP-43 is
a component of the Dicer and Drosha complexes, which are
important formiRNAbiogenesis. TDP-43 selectively regulates pri-
miRNA processing by binding to primary transcripts of speciﬁc
miRNAs. It is reported that mutations in TDP-43 gene causes
differential expression of mature and functional miRNAs such
as miR-132, miR-143 and miR-558 that in turn contribute to
ALS pathology. Interestingly, TDP-43 deﬁciency caused impair-
ment in neurite outgrowth in Neuro2a cells and it was rescued
by over-expressing miR-132 (Kawahara and Mieda-Sato, 2012).
Additionally, elevated expression of miR-9 is also observed in
induced pluripotent stem cell-derived neurons from ALS patient
harboring a mutation in TDP-43 (Zhang et al., 2013). Together,
these data suggest that TDP-43 is required for neuronal differen-
tiation and neurite outgrowth via regulating miRNA biogenesis
pathway and their expression.
Mutations inRNAbinding protein FUS/TLS (FUS/translocated
in liposarcoma) are also found in ALS patients (Kwiatkowski
et al., 2009). Similar to TDP-43, FUS/TLS protein binds to pre-
mRNAmolecules and determines their fate via regulating splicing,
transport, stability, and translation (Lagier-Tourenne et al., 2012).
Recently, it has been shown that FUS/TLS promotes biogenesis of
speciﬁc miRNAs via recruiting Drosha to primary miRNA tran-
scripts. Among them, miRNAs with known function for synaptic
plasticity and neuronal development such as miR-132, miR-134,
and miR-9 were identiﬁed (Morlando et al., 2012). miR-9 regu-
lates axon growth via direct regulation of microtubule-associated
protein 1b (MAP1B) mRNA translation and miR-132 regulates
neuronal morphology and growth by targeting various genes
including acetylcholinesterase andTau (Edbauer et al., 2010; Smith
et al., 2011; Dajas-Bailador et al., 2012; Hebert et al., 2012; Shaltiel
et al., 2013). miR-134 regulates neuronal development and den-
dritogenesis in response to neuronal activity (Fiore et al., 2009).
These results suggest that mutations in FUS/TLS may lead to dis-
turbance in miRNA biogenesis and function, which contributes to
pathological phenotype observed in ALS patients.
In addition to it, miRNA expression in white blood cells from
sporadic ALS patients exhibited distinct expression pattern dur-
ing disease progress. miRNA proﬁling data from 14 patients and
14 controls showed that expression of miR-338-3p is increased
and expression of seven other miRNAs is decreased in leukocyte
from ALS patients (De Felice et al., 2012). Since bloods are more
accessible than motor neurons from patients, this ﬁnding suggests
that proﬁling of miRNA expression from bloods can be used as
a diagnostic tool for ALS. Taken together, we can conclude that
dysregulated miRNA expression contributes to the ALS pathology
and proﬁling of the miRNA expression can serve as a tool for ALS
diagnosis.
SUMMARY AND PERSPECTIVE
With current advanced genetic tools, genetic causes of motor neu-
ron diseases are getting unveiled. However, pathogenesis of motor
neuron disease is extremely complex and not yet fully under-
stood. Due to this reason, efﬁcient cure for motor neuron disease
is currently unavailable. Interestingly, even though the genetic
causes of the diseases are different, their cellular pathomecha-
nisms share common traits; miRNA biogenesis and expression.
Here, we reviewed current knowledge about the role of miRNA
in two common motor neuron diseases, SMA and ALS. Dysreg-
ulated miRNA expression in neuromuscular system may lead to
neurodegeneration and disease pathology. However, the question,
how individual miRNAs contribute to development and mainte-
nance of the NMJ and how their dysregulation may cause ALS or
SMA, requires further investigation.
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